Natarajan R

References (9)

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus - Prabakaran_2026_Mini.Rev.Med.Chem__
Author(s) : Prabakaran A , Sivaperuman A , Natarajan R , Nagarajan NC , Solomon VR
Ref : Mini Rev Med Chem , : , 2026
Abstract :
PubMedSearch : Prabakaran_2026_Mini.Rev.Med.Chem__
PubMedID: 41510718

Title : Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease - Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
Author(s) : Siwaraman B , Vijaykumar R , Velmurugan BA , Natarajan R
Ref : CNS Neurol Disord Drug Targets , : , 2021
Abstract :
PubMedSearch : Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
PubMedID: 34602041

Title : Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease - Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
Author(s) : Siwaraman B , Vijaykumar R , Velmurugan BA , Natarajan R
Ref : CNS Neurol Disord Drug Targets , : , 2021
Abstract :
PubMedSearch : Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
PubMedID: 34602041

Title : Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease - Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
Author(s) : Siwaraman B , Vijaykumar R , Velmurugan BA , Natarajan R
Ref : CNS Neurol Disord Drug Targets , : , 2021
Abstract :
PubMedSearch : Siwaraman_2021_CNS.Neurol.Disord.Drug.Targets__
PubMedID: 34602041

Title : Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome - Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
Author(s) : Tenorio-Laranga J , Peltonen I , Keskitalo S , Duran-Torres G , Natarajan R , Mannisto PT , Nurmi A , Vartiainen N , Airas L , Elovaara I , Garcia-Horsman JA
Ref : Biochemical Pharmacology , 85 :1783 , 2013
Abstract :
PubMedSearch : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
PubMedID: 23643808

Title : Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome - Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
Author(s) : Tenorio-Laranga J , Peltonen I , Keskitalo S , Duran-Torres G , Natarajan R , Mannisto PT , Nurmi A , Vartiainen N , Airas L , Elovaara I , Garcia-Horsman JA
Ref : Biochemical Pharmacology , 85 :1783 , 2013
Abstract :
PubMedSearch : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
PubMedID: 23643808

Title : Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome - Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
Author(s) : Tenorio-Laranga J , Peltonen I , Keskitalo S , Duran-Torres G , Natarajan R , Mannisto PT , Nurmi A , Vartiainen N , Airas L , Elovaara I , Garcia-Horsman JA
Ref : Biochemical Pharmacology , 85 :1783 , 2013
Abstract :
PubMedSearch : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
PubMedID: 23643808